# clm_6BA60CDC0B9D

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: cash_and_equivalents  
value: 254,312,000 United States dollar  
valid_from: 2011-06-30  
valid_to: 2011-09-30  
published: 2011-07-28  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_8F646FBC58B0  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals cash and equivalents: 254,312,000 United States dollar", as of 2011-06-30 (until 2011-09-30). Claim clm_6BA60CDC0B9D, https://asof.is/claim/clm_6BA60CDC0B9D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000120677411001639/0001206774-11-001639-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2011, filed 2011-07-28  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000120677411001639/0001206774-11-001639-index.htm (primary, SEC EDGAR 10-Q Q2 FY2011, published 2011-07-28)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 135,376,000 United States dollar | valid 2011-03-31 to 2011-06-30 | conf 0.95 | superseded | superseded_by [clm_6BA60CDC0B9D](/claim/clm_6BA60CDC0B9D.md) | [clm_9135C6B074D1](/claim/clm_9135C6B074D1.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.